Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ANEB Anebulo Pharmaceuticals, Inc. Common Stock
$0.28 -5.17% -0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ANEB stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)

Loading

Key Stats

Market cap. 11.8M
Enterprise value 2.8M
Trailing PE -1.1000000238419
Forward PE -0.44615385
PEG Ratio 0.024750000536442
Enterprise to EBITDA -0.34383417282209
Price to book MRQ 1.5025907

Financials

Fiscal Year Ends 2025-06-30
Most Recent Quarter (MRQ) 2025-12-31
Diluted EPS TTM -0.19
Total Cash (MRQ) 9.0M
Current ratio (MRQ) 6.242
Operating Cash Flow (TTM) -5840233

ANEB trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ANEB News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.